There is an urgent need to support the development of diverse and differentiated, multi-mechanistic and potentially complementary therapies, that are effective against Covid-19, are unaffected by the threat of viral mutation and, more critically than ever, are easy to make, distribute and take by the patient.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,